GR3036936T3 - Compositions for nasal administration of desmopressin - Google Patents

Compositions for nasal administration of desmopressin

Info

Publication number
GR3036936T3
GR3036936T3 GR20010401804T GR20010401804T GR3036936T3 GR 3036936 T3 GR3036936 T3 GR 3036936T3 GR 20010401804 T GR20010401804 T GR 20010401804T GR 20010401804 T GR20010401804 T GR 20010401804T GR 3036936 T3 GR3036936 T3 GR 3036936T3
Authority
GR
Greece
Prior art keywords
composition
desmopressin
nasal administration
container
assembly
Prior art date
Application number
GR20010401804T
Other languages
English (en)
Inventor
Alan Harris
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of GR3036936T3 publication Critical patent/GR3036936T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Otolaryngology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
GR20010401804T 1993-06-29 2001-10-18 Compositions for nasal administration of desmopressin GR3036936T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8489493A 1993-06-29 1993-06-29
PCT/SE1994/000623 WO1995001183A1 (en) 1993-06-29 1994-06-22 Compositions for nasal administration of desmopressin

Publications (1)

Publication Number Publication Date
GR3036936T3 true GR3036936T3 (en) 2002-01-31

Family

ID=22187889

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20010401804T GR3036936T3 (en) 1993-06-29 2001-10-18 Compositions for nasal administration of desmopressin

Country Status (20)

Country Link
US (1) US5498598A (el)
EP (1) EP0708657B1 (el)
JP (1) JPH09502425A (el)
KR (1) KR100193104B1 (el)
CN (1) CN1101701C (el)
AT (1) ATE203412T1 (el)
CA (1) CA2166312C (el)
CZ (1) CZ282456B6 (el)
DE (1) DE69427820T2 (el)
DK (1) DK0708657T3 (el)
ES (1) ES2158898T3 (el)
GR (1) GR3036936T3 (el)
HK (1) HK1000906A1 (el)
HU (1) HU221617B1 (el)
NZ (1) NZ268442A (el)
PL (1) PL176317B1 (el)
PT (1) PT708657E (el)
RU (1) RU2135204C1 (el)
SK (1) SK282844B6 (el)
WO (1) WO1995001183A1 (el)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5674850A (en) * 1993-12-23 1997-10-07 Ferring Ab High purity desmopressin produced in large single batches
US5482931A (en) * 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions
PT710243E (pt) * 1993-06-29 2000-11-30 Ferring Bv Sintese melhorada de peptidos ciclicos.
SE9400918L (sv) * 1994-03-18 1995-09-19 Anne Fjellstad Paulsen Stabiliserad komposition för oral administrering av peptider
US5763398A (en) * 1996-06-20 1998-06-09 Ferring B.V. Nasal administration of desmopressin
US5916582A (en) * 1996-07-03 1999-06-29 Alza Corporation Aqueous formulations of peptides
GB9614235D0 (en) * 1996-07-06 1996-09-04 Danbiosyst Uk Composition for enhanced uptake of polar drugs from mucosal surfaces
US5922680A (en) * 1996-10-23 1999-07-13 Ferring, B.V. Stabilized composition for oral administration of peptides
US8765177B2 (en) * 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US7153845B2 (en) * 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
JP2001233787A (ja) 2000-02-04 2001-08-28 Patents Exploitation Co Bv 小・中サイズのペプチド含有薬学的組成物
US6641799B2 (en) 2002-04-03 2003-11-04 Nos Spray, Inc. Nasal spray for decongesting nasal passages
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
AU2003269747A1 (en) * 2002-05-15 2003-12-02 Sun Pharmaceutical Industries Limited A stable aqueous composition of a peptide
ES2260563T3 (es) * 2003-11-13 2006-11-01 Ferring B.V. Paquete de blister y forma farmaceutica solida para ello.
SE528446C2 (sv) * 2006-03-02 2006-11-14 Ferring Int Ct Sa Farmaceutisk sammansättning innefattande desmopressin, kiseldioxid och stärkelse
CA2695634C (en) 2007-08-06 2018-01-23 Serenity Pharmaceuticals Corporation Methods and devices for desmopressin drug delivery
CN101372504B (zh) * 2007-08-22 2011-05-18 深圳翰宇药业股份有限公司 一种纯化去氨加压素的方法
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
DK3225250T3 (da) 2008-05-21 2019-11-04 Ferring Bv Orodispersibel desmopressin til forlængelse af den indledende søvnperiode, som ikke forstyrres af nykturi
CN105963834A (zh) * 2008-12-22 2016-09-28 阿勒根公司 鼻内去氨加压素给药
US20100160214A1 (en) * 2008-12-22 2010-06-24 Serenity Pharmaceuticals Corporation Desmopressin composition
AU2015261630B2 (en) * 2008-12-22 2017-09-14 Acerus Pharmaceuticals USA, LLC Intranasal desmopressin administration
DK3679941T3 (da) 2009-06-18 2022-11-14 Serenity Pharmaceuticals Llc Sikker indgivelse af desmopressin
CN102440957B (zh) * 2011-12-16 2013-09-25 深圳市健元医药科技有限公司 醋酸特利加压素鼻腔喷雾剂及其制备方法
AU2015370666B2 (en) 2014-12-22 2020-09-03 Arovella Therapeutics Limited Prevention and treatment of metastatic disease in thrombocytotic cancer patients

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4271068A (en) * 1968-05-10 1981-06-02 Ciba-Geigy Corporation Process for the manufacture of cystine-containing peptides
CH517705A (de) * 1969-12-16 1972-01-15 Ciba Geigy Ag Verfahren zur Herstellung von Cystin-haltigen Peptiden
US3929758A (en) * 1974-09-12 1975-12-30 Armour Pharma Cyclization of cysteine-containing peptides
US4033940A (en) * 1975-11-12 1977-07-05 Armour Pharmaceutical Company Cyclization of peptides
US4093610A (en) * 1977-01-31 1978-06-06 American Home Products Corporation Process for producing triglycyl-lysine vasopressin and intermediates therefor
US4216141A (en) * 1978-07-19 1980-08-05 The Salk Institute For Biological Studies Method for cyclization of peptides
DE2923787A1 (de) * 1979-06-12 1980-12-18 Max Planck Gesellschaft Verfahren zur selektiven bildung von disulfidbruecken in polypeptiden und die dabei erhaltenen produkte als wirkstoffe enthaltende arzneimittel
IE56021B1 (en) * 1982-10-13 1991-03-27 Akzo Nv Peptides
JPS61194034A (ja) * 1985-02-25 1986-08-28 Teijin Ltd 経鼻投与用粉末状組成物
EP0300036A4 (en) * 1987-01-30 1989-06-14 Biomed Res Consultants Ltd PHARMACEUTICAL COMPOSITIONS BASED ON VASOPRESSIN.
US5066716A (en) * 1988-12-13 1991-11-19 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Synthesis of chloroacetyl and bromoacetyl modified peptides for the preparation of synthetic peptide polymers, conjugated peptides, and cyclic peptides
EP0381345B1 (en) * 1989-01-30 1994-07-13 Corint, Ltd. Aqueous liquid desmopressin-CMC pharmaceutical composition
EP0432431B1 (en) * 1989-11-16 1993-06-16 PHIDEA S.p.A. Liquid pharmaceutical composition for nasal administration containing a polypeptide as active ingredient

Also Published As

Publication number Publication date
JPH09502425A (ja) 1997-03-11
ATE203412T1 (de) 2001-08-15
CN1126439A (zh) 1996-07-10
CZ339095A3 (en) 1996-09-11
WO1995001183A1 (en) 1995-01-12
SK165095A3 (en) 1996-11-06
KR960703339A (ko) 1996-08-17
RU2135204C1 (ru) 1999-08-27
PL312204A1 (en) 1996-04-01
CN1101701C (zh) 2003-02-19
HU221617B1 (hu) 2002-12-28
HK1000906A1 (en) 2002-03-08
NZ268442A (en) 1996-09-25
ES2158898T3 (es) 2001-09-16
DE69427820T2 (de) 2001-11-08
US5498598A (en) 1996-03-12
DK0708657T3 (da) 2001-10-15
HU9503833D0 (en) 1996-02-28
HUT73776A (en) 1996-09-30
PL176317B1 (pl) 1999-05-31
SK282844B6 (sk) 2002-12-03
CA2166312A1 (en) 1995-01-12
CZ282456B6 (cs) 1997-07-16
EP0708657B1 (en) 2001-07-25
CA2166312C (en) 2002-04-23
DE69427820D1 (de) 2001-08-30
KR100193104B1 (ko) 1999-06-15
PT708657E (pt) 2001-11-30
EP0708657A1 (en) 1996-05-01

Similar Documents

Publication Publication Date Title
GR3036936T3 (en) Compositions for nasal administration of desmopressin
PL316689A1 (en) Anti-dandruff shampoo
HK1000903A1 (en) Stabilized pharmaceutical peptide compositions
MD1699F2 (ro) Compoziţie apoasă a hormonului somatotrop uman şi procedeu de prevenire a denaturării ei
AU3183389A (en) Human relaxin formulation
HUT64567A (en) Method for producing new cyclosporines and preparations containing said compounds as active agent
CA2016659A1 (en) Stabilized compositions containing epidermal growth factor
CA2203033A1 (en) Compounds and compositions for delivering active agents
CA2308513A1 (en) Method and composition for delivering zinc to the nasal membrane
CA2113995A1 (en) Use of gentisic acid or gentisyl alcohol for stabilising radiolabeled peptides and proteins
GR1003011B (el) Νεα συνθεση
MX9701170A (es) Composicion antitranspirante en aerosol con poco propulsor.
HU9501801D0 (en) Lactame-compounds as pharmaceutical active component
BG103306A (en) Liquid allendronate compositions
BG103632A (en) Pharmaceutical compositions containing ibuprophene and domperidon for migraine treatment
YU40398A (sh) Kompozicija nazalnog spreja za davanje sredstva za lečenje odloženog napada emezisa
AU7037591A (en) Stabilization of t-pa pro
AU6520196A (en) Aqueous compositions containing ciprofloxacine, and related use and process
CA2103667A1 (fr) Nouvelles compositions liquides a base de derives de la piperidine substitues en 1,4
MX9703839A (es) Soluciones intravenosas de lubeluzol.
IT1263107B (it) Composizioni galeniche a base di calcitonina stabilizzate